Alberol-Ila J - Search Results

1

Multifaceted effects of soluble human CD6 in experimental cancer models.

Simões IT, Aranda F, Casadó-Llombart S, Velasco-de Andrés M, Català C, Álvarez P, Consuegra-Fernández M, Orta-Mascaró M, Merino R, Merino J, Alberola-Ila J, González-Aseguinolaza G, Carreras E, Martínez V, Lozano F. Simões IT, et al. Among authors: alberola ila j. J Immunother Cancer. 2020 Mar;8(1):e000172. doi: 10.1136/jitc-2019-000172. J Immunother Cancer. 2020. PMID: 32217757 Free PMC article.

2

Development of Type 2 Innate Lymphoid Cells Is Selectively Inhibited by Sustained E Protein Activity.

Berrett H, Qian L, Roman O, Cordova A, Simmons A, Sun XH, Alberola-Ila J. Berrett H, et al. Among authors: alberola ila j. Immunohorizons. 2019 Dec 18;3(12):593-605. doi: 10.4049/immunohorizons.1900045. Immunohorizons. 2019. PMID: 31852728 Free PMC article.

3

Suppression of ILC2 differentiation from committed T cell precursors by E protein transcription factors.

Qian L, Bajana S, Georgescu C, Peng V, Wang HC, Adrianto I, Colonna M, Alberola-Ila J, Wren JD, Sun XH. Qian L, et al. Among authors: alberola ila j. J Exp Med. 2019 Apr 1;216(4):884-899. doi: 10.1084/jem.20182100. Epub 2019 Mar 21. J Exp Med. 2019. PMID: 30898894 Free PMC article.

4

West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.

Kovats S, Turner S, Simmons A, Powe T, Chakravarty E, Alberola-Ila J. Kovats S, et al. Among authors: alberola ila j. Clin Exp Immunol. 2016 Nov;186(2):214-226. doi: 10.1111/cei.12850. Epub 2016 Sep 22. Clin Exp Immunol. 2016. PMID: 27513522 Free PMC article.

5

Retroviral Transduction of T Cells and T Cell Precursors.

Simmons A, Alberola-Ila J. Simmons A, et al. Among authors: alberola ila j. Methods Mol Biol. 2016;1323:99-108. doi: 10.1007/978-1-4939-2809-5_8. Methods Mol Biol. 2016. PMID: 26294401 Free PMC article.

6

Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses.

Fenutría R, Martinez VG, Simões I, Postigo J, Gil V, Martínez-Florensa M, Sintes J, Naves R, Cashman KS, Alberola-Ila J, Ramos-Casals M, Soldevila G, Raman C, Merino J, Merino R, Engel P, Lozano F. Fenutría R, et al. Among authors: alberola ila j. PLoS One. 2014 Jan 15;9(1):e84895. doi: 10.1371/journal.pone.0084895. eCollection 2014. PLoS One. 2014. PMID: 24454761 Free PMC article.

7

Increased level of E protein activity during invariant NKT development promotes differentiation of invariant NKT2 and invariant NKT17 subsets.

Hu T, Wang H, Simmons A, Bajaña S, Zhao Y, Kovats S, Sun XH, Alberola-Ila J. Hu T, et al. Among authors: alberola ila j. J Immunol. 2013 Nov 15;191(10):5065-73. doi: 10.4049/jimmunol.1301546. Epub 2013 Oct 11. J Immunol. 2013. PMID: 24123679 Free PMC article.

8

Control of early stages in invariant natural killer T-cell development.

Hu T, Gimferrer I, Alberola-Ila J. Hu T, et al. Among authors: alberola ila j. Immunology. 2011 Sep;134(1):1-7. doi: 10.1111/j.1365-2567.2011.03463.x. Epub 2011 Jun 30. Immunology. 2011. PMID: 21718314 Free PMC article. Review.

9

The Ras/MAPK pathway is required for generation of iNKT cells.

Hu T, Gimferrer I, Simmons A, Wiest D, Alberola-Ila J. Hu T, et al. Among authors: alberola ila j. PLoS One. 2011 May 10;6(5):e19890. doi: 10.1371/journal.pone.0019890. PLoS One. 2011. PMID: 21572967 Free PMC article.

10

Regulation of GATA-3 expression during CD4 lineage differentiation.

Gimferrer I, Hu T, Simmons A, Wang C, Souabni A, Busslinger M, Bender TP, Hernandez-Hoyos G, Alberola-Ila J. Gimferrer I, et al. Among authors: alberola ila j. J Immunol. 2011 Apr 1;186(7):3892-8. doi: 10.4049/jimmunol.1003505. Epub 2011 Feb 25. J Immunol. 2011. PMID: 21357543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results